Application of paclitaxel-eluting metal stents in renal artery of pig model

Journal of Endourology

Volumn 21, Issue 12, 2007, Pages 1571-1576

  Voudoukis, Theodore ^a   Liatsikos, Evangelos N ^a,c   Kagadis, George C ^a   Christeas, Nicolaos ^a   Flaris, Nicolaos ^a   Katsanos, Konstantinos ^a   Costantinides, Constantinos ^b   Perimenis, Petros ^a   Scopa, Chrisoula D ^a   Filos, Kriton S ^a   Nikiforidis, George C ^a   Alexopoulos, Dimitrios ^a   Siablis, Dimitrios ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c UNIVERSITY OF PATRAS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL;

ANIMAL EXPERIMENT; ARTICLE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTROLLED STUDY; CORONARY STENT; DIGITAL SUBTRACTION ANGIOGRAPHY; DRUG ELUTING STENT; ENDOSCOPY; EXPERIMENTAL STUDY; FEMALE; GILT (SWINE); NONHUMAN; PRIORITY JOURNAL; RENAL ARTERY;

ANGIOGRAPHY; ANGIOSCOPY; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BLOOD VESSEL PROSTHESIS IMPLANTATION; COATED MATERIALS, BIOCOMPATIBLE; DISEASE MODELS, ANIMAL; FEMALE; PACLITAXEL; PROSTHESIS DESIGN; RENAL ARTERY OBSTRUCTION; STENTS; SWINE; TREATMENT OUTCOME;

EID: 38049152951     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2006.0199     Document Type: Article

References (22)

1. Beutler JJ, Van Ampting JM, Van De Ven PJ, Koomans HA, Beek FJ, Woittiez AJ, Mali WP. Long-term effects of arterial stenting on kidney function for patients with ostial atherosclerotic renal artery stenosis and renal insufficiency. J Am Soc Nephrol 2001;12:1475-1481.
2. Siablis D, Liatsikos EN, Kalogeropoulou C, Karnabatidis D, Tsota I, Perimenis P, Passakos C, Barbalias GA. Metal stents for the management of atherosclerotic renovascular disease. J Endourol 2001;15:993-996.
3. Yutan E, Glickerman DJ, Caps MT, Hatsukami T, Harley JD, Kohler TR, Davies MG. Percutaneous transluminal revascularization for renal artery stenosis: Veterans Affairs Puget Sound Health Care System experience. J Vasc Surg 2001;34:685-693.
4. Heldman AW, Cheng L, Jenkins GM, et al. Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis. Circulation 2001;103:2289-2295.
5. Hong MK, Kornowski R, Bramwell O, Ragheb AO, Leon MB. Paclitaxel-coated Gianturco-Roubin II (GR II) stents reduce neointimal hyperplasia in a porcine coronary in-stent restenosis model. Coron Artery Dis 2001;12:513-515.
6. Jenkins NP, Prendergast BD, Thomas M. Drug eluting coronary stents. BMJ 2002;325:1315-1316.
7. Kataoka T, Grube E, Honda Y, et al. 7-hexanoyltaxol-eluting stent for prevention of neointimal growth: An intravascular ultrasound analysis from the Study to COmpare REstenosis rate between QueST and QuaDS-QP2 (SCORE). Circulation 2002;106:1788-1793.
8. Liistro F, Stankovic G, Di Mario C, et al. First clinical experience with a paclitaxel derivate-eluting polymer stent system implantation for in-stent restenosis: immediate and long-term clinical and angiographic outcome. Circulation 2002;105:1883-1886.
9. Lin PH, Chronos NA, Marijianowski MM, Chen C, Conklin B, Bush RL, Lumsden AB, Hanson SR. Carotid stenting using heparin-coated balloon-expandable stent reduces intimal hyperplasia in a baboon model. J Surg Res 2003;112:84-90.
10. Serruys PW, Emanuelsson H, van der Giessen W, et al. Heparin-coated Palmaz-Schatz stents in human coronary arteries. Early outcome of the Benestent-II Pilot Study. Circulation 1996;93:412-422.
11. Whelan DM, van der Giessen WJ, Krabbendam SC, van Vliet EA, Verdouw PD, Serruys PW, van Beuseom HM. Biocompatibility of phosphorylcholine coated stents in normal porcine coronary arteries. Heart 2000;83:338-345.
12. Windecker S, Mayer I, De Pasquale G, et al. Stent coating with titanium-nitride-oxide for reduction of neointimal hyperplasia. Circulation 2001;104:928-933.
13. Babapulle MN, Eisenberg M. Coated stents for the prevention of restenosis: Part I. Circulation 2002;106:2734-2740.
14. Babapulle MN, Eisenberg MJ. Coated stents for the prevention of restenosis: Part II. Circulation 2002;106:2859-2866.
15. Bar FW, van der Veen FH, Benzina A, Habets J, Koole LH. New biocompatible polymer surface coating for stents results in a low neointimal response. J Biomed Mater Res 2000;52:193-198.
16. Bennett MR. In-stent stenosis: Pathology and implications for the development of drug eluting stents. Heart 2003;89:218-224.
17. Farb A, Heller PF, Shroff S, et al. Pathological analysis of local delivery of paclitaxel via a polymer-coated stent. Circulation 2001;104:473-479.
18. Gershlick AH, Baron J. Dealing with in-stent restenosis. Heart 1998;79:319-323.
19. Kolodgie FD, John M, Khurana C, et al. Sustained reduction of instent neointimal growth with the use of a novel systemic nanoparticle paclitaxel. Circulation 2002;106:1195-1198.
20. Virmani R, Liistro F, Stankovic G, Di Mario C, Montorfano M, Farb A, Kolodgie FD, Colombo A. Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humans. Circulation 2002;106:2649-2651.
21. Liatsikos EN, Karnabatidis D, Kagadis GC, et al. Application of paclitaxel-eluting metal mesh stents within the pig ureter: An experimental study. Eur Urol 2007;51:217-223.
22. Granillo GA, van Dijk LC, McFadden EP, Serruys PW. Percutaneous radial intervention for complex bilateral renal artery stenosis using paclitaxel eluting stents. Catheter Cardiovasc Interv 2005;64:23-27.